Navigation Links
Developing Nations to Get Gardasil at Lesser Rates from Merck Soon

Pharma giant Merck and Co., hopes to offer Gardasil, to developing countries at affordable rates.// Gardasil, marketed by Merck is the only vaccine against Human Papilloma Virus, that is insinuated to cause the deadly cervical cancer.

Statistics reveal that cervical cancer is rampant in developing countries.80% of deaths attributed to cervical cancer is seen to occur in developing nations.

A single dose of Gardasil is priced at 120 €.The vaccination programme advises three doses for effective protection. This does not make it practical for distribution in developing nations.

Merck officials have notified that the company hopes to make the vaccine available in the market at lower prices in developing countries in a couple of months.

Health experts across the globe have been lobbying to make this vaccine available to all young sexually active women, to get protection against HPV which is a sexually transmitted virus. Statistics show that at least 95% women are never get a cervical smear done, without which a positive diagnosis for cervical cancer cannot be reached.

The vaccine is currently available in 13 European Union countries and also in United States. Merck has vouched that they are indeed committed to reduce the usual time lag of about two decades that pass from the date of approval of medicines in the West and the point they reach poorer nations.


MST
'"/>




Page: 1

Related medicine news :

1. Risk Of Developing Arthritis
2. Developing HIV fighter
3. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
4. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
5. Men Who at Risk Of Developing Prostate Cancer
6. Identifying The Risks Of Developing Schizophrenia
7. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
8. Cancer Patients At A Greater Risk Of Developing Blood Clots
9. Young Smokers at Increased Risk Of Developing a Heart Attack
10. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... March 30, 2017 , ... This morning, more ... Trump expressing their support for an independent Vaccine Safety Commission. Five of the ... medical journalist, will hold a press conference at 9:00 AM Friday, March ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
(Date:3/29/2017)... ... March 30, 2017 , ... Grass pollen is the main cause of hay fever in ... The season for grass pollen runs from May to July each year; with the worst ... to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sublime Naturals ... "Spice of Life" or "Wonder Spice", it has been used for thousands of years. ... the East," says Heshelow, author of " Turmeric: How to Use it For Your ...
(Date:3/29/2017)... Baton Rouge, Louisiana (PRWEB) , ... March 29, ... ... trademarked HeartBoost in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, ... campaign at Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  Bodycad announced today that it ... 510(k) clearance for its Bodycad Unicompartmental Knee System, ... orthopaedic restoration. Bodycad is the first Canadian company ... implant system. Bodycad,s revolutionary Unicompartmental ... of the patient,s unique anatomical features and kinematics. ...
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets has ... 2017-2021" report to their offering. ... The global energy-based aesthetic devices market to ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has ... industry experts. The report covers the market landscape and its growth ...
(Date:3/29/2017)... -- Global intravenous (IV) iron and oral iron market is ... a CAGR of 5%. Iron drugs are ... anemia or other iron deficiencies. Oral iron supplements are recommended ... some cases, oral administrations are not capable of maintaining the ... comes into the picture. Global Intravenous (IV) Iron ...
Breaking Medicine Technology: